Intensive timed chemotherapy for 51 acute myeloid leukemia patients with poor prognosis. 1985

D Fiere, and L Campos, and B Coiffier, and J M Extra, and M Ffrench, and D Guyotat, and D Ritouet, and V V Huan

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

D Fiere, and L Campos, and B Coiffier, and J M Extra, and M Ffrench, and D Guyotat, and D Ritouet, and V V Huan
April 1996, Hematology and cell therapy,
D Fiere, and L Campos, and B Coiffier, and J M Extra, and M Ffrench, and D Guyotat, and D Ritouet, and V V Huan
October 2001, Medical and pediatric oncology,
D Fiere, and L Campos, and B Coiffier, and J M Extra, and M Ffrench, and D Guyotat, and D Ritouet, and V V Huan
June 2017, Turkish journal of haematology : official journal of Turkish Society of Haematology,
D Fiere, and L Campos, and B Coiffier, and J M Extra, and M Ffrench, and D Guyotat, and D Ritouet, and V V Huan
February 1997, Leukemia research,
D Fiere, and L Campos, and B Coiffier, and J M Extra, and M Ffrench, and D Guyotat, and D Ritouet, and V V Huan
June 1987, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
D Fiere, and L Campos, and B Coiffier, and J M Extra, and M Ffrench, and D Guyotat, and D Ritouet, and V V Huan
March 2020, Clinical hematology international,
D Fiere, and L Campos, and B Coiffier, and J M Extra, and M Ffrench, and D Guyotat, and D Ritouet, and V V Huan
February 1986, Cancer treatment reports,
D Fiere, and L Campos, and B Coiffier, and J M Extra, and M Ffrench, and D Guyotat, and D Ritouet, and V V Huan
March 2014, Haematologica,
D Fiere, and L Campos, and B Coiffier, and J M Extra, and M Ffrench, and D Guyotat, and D Ritouet, and V V Huan
May 2019, Clinical lymphoma, myeloma & leukemia,
D Fiere, and L Campos, and B Coiffier, and J M Extra, and M Ffrench, and D Guyotat, and D Ritouet, and V V Huan
January 1990, Haematology and blood transfusion,
Copied contents to your clipboard!